Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NanoSonic Products and Florida Biologix have signed a contract for the formulation and filling of the sterile liquid form of Trappsol Cyclo product.
Subscribe to our email newsletter
NanoSonic’s Trappsol Cyclo is FDA and EMEA designated orphan drug for the treatment of Niemann Pick Type-C disease, also known as Childhood Alzheimer’s.
Trappsol Cyclo is currently being administered in the US under a compassionate use IND.
Florida Biologix will formulate, fill, label, test and package 3,000 vials of this therapy for patients with this devastating disease.
Childhood Alzheimer’s affects children and adults and manifests with progressive neurological symptoms.